In the end, whether they be via reimbursement/rebate or direct sales, sales are sales and so far nothing from regions that they have been able to sell in such as Europe and parts of South America which should be a concern to any investor in this company. Maybe the Endo product will be the one that breaks for this company.
In the end, whether they be via reimbursement/rebate or direct...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.010(2.70%) |
Mkt cap ! $58.92M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 36.0¢ | $42.78K | 116.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1408 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 111109 | 2 |
View Market Depth
| Last trade - 13.47pm 31/07/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |